How Hong Kong can cement its position as a biotech listing hub

A researcher prepares a sample inside a laboratory at BeiGene Ltd’s research and development centre in Beijing on May 24, 2018. The company made its Hong Kong trading debut in August 2018. Photo: Bloomberg